Yi-Zhou Jiang

3.1k total citations
41 papers, 1.5k citations indexed

About

Yi-Zhou Jiang is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Yi-Zhou Jiang has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 28 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Yi-Zhou Jiang's work include Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (13 papers) and Breast Lesions and Carcinomas (11 papers). Yi-Zhou Jiang is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (13 papers) and Breast Lesions and Carcinomas (11 papers). Yi-Zhou Jiang collaborates with scholars based in China, United States and India. Yi-Zhou Jiang's co-authors include Ke‐Da Yu, Yi‐Rong Liu, Zhi‐Ming Shao, Xiao‐En Xu, Zhi-Ming Shao, Xi Jin, Zhi‐Ming Shao, Gen‐Hong Di, Ding Ma and Xin Hu and has published in prestigious journals such as Nature Communications, Genes & Development and PLoS ONE.

In The Last Decade

Yi-Zhou Jiang

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Zhou Jiang China 23 827 681 648 282 172 41 1.5k
Yi‐Rong Liu China 22 862 1.0× 865 1.3× 523 0.8× 343 1.2× 119 0.7× 44 1.6k
Jeremy Force United States 19 588 0.7× 653 1.0× 616 1.0× 273 1.0× 215 1.3× 49 1.4k
Katherine E. Hutchinson United States 19 595 0.7× 972 1.4× 920 1.4× 536 1.9× 201 1.2× 48 1.8k
Craig P. Giacomini United States 16 510 0.6× 780 1.1× 417 0.6× 324 1.1× 177 1.0× 18 1.3k
Paul J. van Diest Netherlands 22 454 0.5× 833 1.2× 549 0.8× 184 0.7× 286 1.7× 40 1.6k
Dmitriy Sonkin United States 16 450 0.5× 845 1.2× 640 1.0× 191 0.7× 132 0.8× 31 1.4k
Marzia Locatelli Italy 17 535 0.6× 329 0.5× 757 1.2× 221 0.8× 131 0.8× 36 1.2k
Heini Lassus Finland 25 555 0.7× 1.0k 1.5× 830 1.3× 179 0.6× 232 1.3× 44 2.0k
Boris Winterhoff United States 21 418 0.5× 749 1.1× 462 0.7× 180 0.6× 138 0.8× 56 1.5k
Nikita Makretsov Canada 14 380 0.5× 682 1.0× 593 0.9× 164 0.6× 195 1.1× 19 1.4k

Countries citing papers authored by Yi-Zhou Jiang

Since Specialization
Citations

This map shows the geographic impact of Yi-Zhou Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Zhou Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Zhou Jiang more than expected).

Fields of papers citing papers by Yi-Zhou Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Zhou Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Zhou Jiang. The network helps show where Yi-Zhou Jiang may publish in the future.

Co-authorship network of co-authors of Yi-Zhou Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Zhou Jiang. A scholar is included among the top collaborators of Yi-Zhou Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Zhou Jiang. Yi-Zhou Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yi, Ying Xu, Han Wang, et al.. (2025). HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer. Cell Metabolism. 37(10). 2030–2047.e7. 2 indexed citations
2.
Jiang, Yi-Zhou, Kai Ma, Cheng Cui, Zhuoya Li, & Xiao-Yong Wang. (2025). Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication. BMC Gastroenterology. 25(1). 273–273.
3.
Jin, Xi, Xiao‐En Xu, Yi-Zhou Jiang, et al.. (2019). The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science Advances. 5(3). eaat9820–eaat9820. 96 indexed citations
4.
5.
Zhao, Ya-Xin, Yi‐Rong Liu, Shaowei Xie, Yi-Zhou Jiang, & Zhi‐Ming Shao. (2019). A Nomogram Predicting Lymph Node Metastasis in T1 Breast Cancer based on the Surveillance, Epidemiology, and End Results Program. Journal of Cancer. 10(11). 2443–2449. 26 indexed citations
6.
Zhao, Shen, Xiyu Liu, Xi Jin, et al.. (2019). Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer. Theranostics. 9(17). 4935–4945. 40 indexed citations
7.
Hao, Shuang, et al.. (2018). Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer. The Breast. 43. 97–104. 23 indexed citations
8.
He, Min, et al.. (2017). The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer. Oncotarget. 8(27). 44870–44880. 16 indexed citations
9.
Jiang, Yi-Zhou, Yi‐Rong Liu, Xiao‐En Xu, et al.. (2016). Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Cancer Research. 76(8). 2105–2114. 157 indexed citations
10.
Jin, Xi, Yi-Zhou Jiang, Sheng Chen, et al.. (2016). A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer. BMC Cancer. 16(1). 606–606. 9 indexed citations
11.
Liu, Yi‐Rong, Yi-Zhou Jiang, Xiao‐En Xu, et al.. (2016). Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer. Clinical Cancer Research. 22(7). 1653–1662. 71 indexed citations
12.
Jin, Xi, Yi-Zhou Jiang, Sheng Chen, Zhi‐Ming Shao, & Gen‐Hong Di. (2016). A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients. Scientific Reports. 6(1). 32585–32585. 22 indexed citations
13.
Jiang, Yi-Zhou, Xiao‐En Xu, Xin Hu, et al.. (2016). Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer. Clinical Cancer Research. 22(19). 4859–4869. 62 indexed citations
14.
Liu, Yi‐Rong, Yi-Zhou Jiang, Xiao‐En Xu, et al.. (2016). Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Breast Cancer Research. 18(1). 33–33. 175 indexed citations
15.
Yu, Ke‐Da, Yi-Zhou Jiang, Shuang Hao, & Zhi-Ming Shao. (2015). Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer. BMC Medicine. 13(1). 254–254. 26 indexed citations
16.
Yu, Ke‐Da, Yi-Zhou Jiang, & Zhi‐Ming Shao. (2015). Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype. Oncotarget. 6(18). 16686–16697. 8 indexed citations
17.
Hu, Xin, et al.. (2014). Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer. Annals of Surgical Oncology. 21(S4). 648–656. 10 indexed citations
18.
Jiang, Yi-Zhou, et al.. (2014). Favorable Prognostic Impact in Loss of TP53 and PIK3CA Mutations after Neoadjuvant Chemotherapy in Breast Cancer. Cancer Research. 74(13). 3399–3407. 35 indexed citations
19.
Liu, Yi‐Rong, Yi-Zhou Jiang, Ke‐Da Yu, & Zhi‐Ming Shao. (2014). Different Patterns in the Prognostic Value of Age for Breast Cancer-Specific Mortality Depending on Hormone Receptor Status: A SEER Population-Based Analysis. Annals of Surgical Oncology. 22(4). 1102–1110. 26 indexed citations
20.
Chen, Sheng, Yi-Zhou Jiang, Liang Huang, et al.. (2013). The Residual Tumor Autophagy Marker LC3B Serves as a Prognostic Marker in Local Advanced Breast Cancer after Neoadjuvant Chemotherapy. Clinical Cancer Research. 19(24). 6853–6862. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Rong Liu Breakdown of academic impact, for papers by Jeremy Force Breakdown of academic impact, for papers by Katherine E. Hutchinson Breakdown of academic impact, for papers by Craig P. Giacomini Breakdown of academic impact, for papers by Paul J. van Diest Breakdown of academic impact, for papers by Dmitriy Sonkin Breakdown of academic impact, for papers by Marzia Locatelli Breakdown of academic impact, for papers by Heini Lassus Breakdown of academic impact, for papers by Boris Winterhoff Breakdown of academic impact, for papers by Nikita Makretsov
Rankless by CCL
2026